1. Home
  2. AFYA vs SPTX Comparison

AFYA vs SPTX Comparison

Compare AFYA & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Afya Limited

AFYA

Afya Limited

HOLD

Current Price

$14.22

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$24.08

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AFYA
SPTX
Founded
1999
N/A
Country
Brazil
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
AFYA
SPTX
Price
$14.22
$24.08
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
101.2K
106.4K
Earning Date
05-08-2026
N/A
Dividend Yield
4.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.43
N/A
Revenue Next Year
$7.15
N/A
P/E Ratio
$9.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.00
$17.59
52 Week High
$16.47
$26.32

Technical Indicators

Market Signals
Indicator
AFYA
SPTX
Relative Strength Index (RSI) 53.46 64.32
Support Level $13.44 $18.72
Resistance Level $14.78 N/A
Average True Range (ATR) 0.47 1.54
MACD 0.07 0.04
Stochastic Oscillator 72.73 57.03

Price Performance

Historical Comparison
AFYA
SPTX

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: